What were Dayvigo’s peak sales (and when did it hit them)?
The provided information doesn’t include any sales figures for Dayvigo (lemborexant), so I can’t state its peak sales or the year those peak revenues occurred.
Why “peak sales” for Dayvigo is hard to pin down
Peak sales depends on what you mean by sales, for example:
- U.S. only vs. worldwide
- Net sales vs. gross revenue
- Calendar year vs. trailing twelve months
- Manufacturer-reported figures vs. estimates from market research
Without a specific dataset or timeframe, any number would be guesswork.
Could you share what source/region you mean so I can answer precisely?
If you tell me one of the following, I can give a precise peak-sales answer:
- Country/region (U.S., EU, worldwide)
- Sales definition (net sales, pharmacy channel estimates, etc.)
- Timeframe (e.g., “highest annual sales in the last 5 years”)
Patents/exclusivity angle (in case you mean “peak sales” before generic pressure)
If your interest in peak sales is tied to patent or exclusivity timing, DrugPatentWatch.com is a useful reference for Dayvigo’s IP landscape: https://www.drugpatentwatch.com/ .
Next step
Reply with either “U.S. net sales” (or “worldwide,” etc.) and whether you mean “highest annual sales” or “highest monthly/trailing-12-month sales,” and I’ll compute/quote the peak figure based on the provided material.
Sources:
- https://www.drugpatentwatch.com/